epirubicin has been researched along with Chronic Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Irie, T; Koizumi, W; Matsunaga, K; Minamino, T; Murano, J; Ogasawara, G; Shibuya, A; Watanabe, M; Woodhams, R | 1 |
| Koyama, I; Nishino, S; Toma, H; Tomoe, H; Uda, M | 1 |
2 other study(ies) available for epirubicin and Chronic Kidney Failure
| Article | Year |
|---|---|
Benefits and problems of transarterial therapy in patients with hepatocellular carcinoma and chronic kidney disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Cohort Studies; Combined Modality Therapy; Epirubicin; Ethiodized Oil; Feasibility Studies; Female; Gelatin Sponge, Absorbable; Humans; Kidney Failure, Chronic; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Treatment Outcome | 2014 |
[Plasma concentration of 4'-epi-adriamycin in hemodialysis patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Humans; Kidney Failure, Chronic; Methotrexate; Middle Aged; Renal Dialysis; Urinary Bladder Neoplasms; Vinblastine | 1992 |